<VariationArchive VariationID="1698553" VariationName="NC_000009.11:g.(6620320_6644613)_(6645693_?)del" VariationType="Deletion" Accession="VCV001698553" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-06-10" DateCreated="2022-08-03" MostRecentSubmission="2022-08-03">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1690930" VariationID="1698553">
      <GeneList>
        <Gene Symbol="GLDC" FullName="glycine decarboxylase" GeneID="2731" HGNC_ID="HGNC:4313" Source="submitted" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>9p24.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" start="6532467" stop="6645729" display_start="6532467" display_stop="6645729" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="9" Accession="NC_000009.11" start="6532463" stop="6645691" display_start="6532463" display_stop="6645691" Strand="-" />
          </Location>
          <OMIM>238300</OMIM>
        </Gene>
      </GeneList>
      <Name>NC_000009.11:g.(6620320_6644613)_(6645693_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>9p24.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" forDisplay="true" AssemblyStatus="previous" Chr="9" Accession="NC_000009.11" outerStart="6620320" innerStart="6644613" innerStop="6645693" display_start="6620320" display_stop="6645693" variantLength="25374" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000009.11" sequenceAccession="NC_000009" sequenceVersion="11" change="g.(6620320_6644613)_(6645693_?)del" Assembly="GRCh37">
            <Expression>NC_000009.11:g.(6620320_6644613)_(6645693_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000009.11:g.(6620320_6644613)_(6645693_?)del AND Non-ketotic hyperglycinemia" Accession="RCV002271830" Version="1">
        <ClassifiedConditionList TraitSetID="3243">
          <ClassifiedCondition DB="MedGen" ID="C0751748">Non-ketotic hyperglycinemia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-06-14" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-06-14" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2022-08-03" MostRecentSubmission="2022-08-03">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">11592811</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">17361008</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">27362913</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="3243" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1933" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Nonketotic hyperglycinemia</ElementValue>
                <XRef ID="HP:0008288" DB="Human Phenotype Ontology" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Non-ketotic hyperglycinemia</ElementValue>
                <XRef ID="Glycine+Encephalopathy/3115" DB="Genetic Alliance" />
                <XRef ID="237939006" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Glycine encephalopathy</ElementValue>
                <XRef ID="MONDO:0011612" DB="MONDO" />
                <XRef Type="Phenotypic series" ID="PS605899" DB="OMIM" />
                <XRef ID="407" DB="Orphanet" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">NKH</ElementValue>
                <XRef Type="MIM" ID="605899" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Nonketotic hyperglycinemia (NKH) is the inborn error of glycine metabolism defined by deficient activity of the glycine cleavage enzyme system (GCS), which results in accumulation of large quantities of glycine in all body tissues including the brain. Based on ultimate outcome NKH is categorized into severe NKH (no developmental progress and intractable epilepsy) and attenuated NKH (variable developmental progress and treatable or no epilepsy). The majority of children with NKH have onset in the neonatal period manifest as progressive lethargy evolving into profound coma and marked hypotonia; 85% have severe NKH and 15% attenuated NKH. Those with onset between two weeks and three months typically present with hypotonia; 50% have severe NKH and 50% attenuated NKH. Those with onset after age three months have attenuated NKH. Severe versus attenuated NKH is consistent within families, but the degree of developmental progress in those with attenuated NKH can vary.</Attribute>
                <XRef ID="NBK1357" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="7219" />
                <XRef ID="7219" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301531</ID>
                <ID Source="BookShelf">NBK1357</ID>
              </Citation>
              <XRef ID="407" DB="Orphanet" />
              <XRef ID="C0751748" DB="MedGen" />
              <XRef ID="MONDO:0011612" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS605899" DB="OMIM" />
              <XRef Type="primary" ID="HP:0008288" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="5001147" SubmissionDate="2022-07-29" DateLastUpdated="2022-08-03" DateCreated="2022-08-03">
        <ClinVarSubmissionID localKey="NC_000009.11:g.(6620320_6644613)_(6645693_?)del|MedGen:C0751748" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002555861" DateUpdated="2022-08-03" DateCreated="2022-08-03" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-06-14">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">27362913</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">17361008</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">11592811</ID>
          </Citation>
          <Comment>Variant summary: The variant identified by MLPA or other technology involves the deletion of exons 1-2 in the GLDC gene. A presumed nomenclature of c.(?_-194)_(334+1_335-1)del has been designated for the purposes of this classification. Although exact breakpoints of this deletion are not known, it is expected to result in an absent or shortened protein product, a known mechanism of disease. A large deletion (92,896 bp) that includes exons 1 and 2 of the GLDC gene was found at a frequency of 0.00061 in 21306 control chromosomes (gnomAD structural variants dataset). This frequency is not higher than the estimated maximum expected for a pathogenic variant in GLDC causing Glycine Encephalopathy (Non-Ketotic Hyperglycinemia) (0.0031), allowing no conclusion about variant significance. Several variants, described as deletion of exons 1-2, have been reported in the literature in compound heterozygous and homozygous form in individuals affected with Glycine Encephalopathy (Non-Ketotic Hyperglycinemia) (Applegarth_2001, Kanno_2007, Coughlin_2017 / LOVD database). These data indicate that the variant is likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GLDC" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000009.11:g.(6620320_6644613)_(6645693_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0751748" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11876943</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5001147" TraitType="Disease" MappingType="XRef" MappingValue="C0751748" MappingRef="MedGen">
        <MedGen CUI="C0751748" Name="Non-ketotic hyperglycinemia" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>